Normon and curasept, italy’s leading oral health company, announce a strategic alliance to launch innovative oral health care products

Normon, a leading family-owned company in the Spanish pharmaceutical sector, and Curasept, an Italian brand at the forefront of innovation in oral health, have signed a collaboration agreement for the joint development, distribution and marketing of an innovative line of oral care products for sale in pharmacies and recommendation in dental clinics.

This alliance, which is Curasept’s first in Spain, and which grants Normon exclusive distribution of their products, will combine Normon’s extensive experience in the manufacture of pharmaceutical products as well as talent in the distribution network in Spain with Curasept’s technological innovation and proprietary formulations, recognized for their efficacy and tolerance in oral treatments.

“This collaboration signifies an important step in our involvement in oral care”, commented Jesús Govantes García, CEO of Normon. “From our position as leaders in the dental sector, we continue to expand our portfolio with solutions that meet the real needs of patients, whether for treatments carried out in clinics or for follow-up care provided by pharmacies. Our commitment is to offer effective, safe, and accessible products that help professionals and patients through every stage of treatment”.

Meanwhile, Giulia Giovannardi, International Business Development Manager at Curasept S.p.A., stated: “Spain is a key market for us, and doing so alongside Normon allows us to reach more patients with effective and safe solutions. This alliance strengthens our international presence and our commitment to oral health”.

The new launches, which provide a complete approach to oral care and are now available in pharmacies, include a complete range of products with chlorhexidine, Bucomed Pro Chlorhexidine by Curasept, formulated with ADS® (Anti Discoloration System) technology, designed, developed and patented by the Italian company in 2002 to prevent tooth staining, the most common side effect of chlorhexidine.

With the addition of Bucomed Pro Chlorhexidine by Curasept, we are expanding Normon’s line of professional oral care recommendations, which also includes AfteRapid by Curasept, a range of products for the treatment and healing of canker sores and lesions of the oral mucosa, launched in March 2025.

Strength in oral health

Normon leads the Spanish dental market in anesthetics with a 61.2% share and offers one of the most comprehensive catalogs in the sector, helping dental professionals to offer the best care to their patients.

With more than 85 years of experience and a solid pharmaceutical vocation, Normon develops, manufactures and markets its products at its plant in Tres Cantos (Madrid), one of the largest and most innovative in Europe. Every second four Normon treatments are dispensed, highlighting their 18.4% market share in generic drugs and the most comprehensive vade mecum in the industry. In addition, the pharmaceutical company continues to focus on self-care, with more than 200 products, reinforcing the company’s purpose: to be close to those who care for others and those who care for themselves.

Curasept is an Italian family-owned company founded in 2001 and focused exclusively to oral health, a field in which the company has become a market leader in Italy due to its commitment to research and development, with functional, reliable and innovative solutions for oral hygiene. Currently, more than 35,000 Italian dental clinics work with Curasept, and their products are available in 99.7% of the pharmacies in the country.

Press contact: comunicacion@normon.com